{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T19:59:36Z","timestamp":1793131176747,"version":"4.5.0"},"reference-count":30,"publisher":"BMJ","issue":"1","license":[{"start":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T00:00:00Z","timestamp":1781654400000},"content-version":"unspecified","delay-in-days":16,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004359","name":"Vetenskapsr\u00e5det","doi-asserted-by":"publisher","award":["2021-06370"],"award-info":[{"award-number":["2021-06370"]}],"id":[{"id":"10.13039\/501100004359","id-type":"DOI","asserted-by":"publisher"}]},{"name":"NIHR Oxford Health Biomedical Research Centre","award":["Not Applicable"],"award-info":[{"award-number":["Not Applicable"]}]},{"name":"Swedish Research Council for Health, Working Life and Welfare","award":["2018-01409"],"award-info":[{"award-number":["2018-01409"]}]},{"name":"Swedish state under the agreement between the Swedish government and the county councils, ALF-agreement","award":["ALFGBG-1005131"],"award-info":[{"award-number":["ALFGBG-1005131"]}]},{"name":"Kurt and Ingrid Dahr\u00e9n Foundation","award":["Not Applicable"],"award-info":[{"award-number":["Not Applicable"]}]},{"name":"Swedish Research Council","award":["2022-06083"],"award-info":[{"award-number":["2022-06083"]}],"id":[{"id":"https:\/\/ror.org\/03zttf063","id-type":"ROR","asserted-by":"crossref"}]},{"name":"Swedish Research Council","award":["2023-06487"],"award-info":[{"award-number":["2023-06487"]}],"id":[{"id":"https:\/\/ror.org\/03zttf063","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Ment Health"],"accepted":{"date-parts":[[2026,5,26]]},"published-print":{"date-parts":[[2026,6]]},"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Patients in forensic psychiatric care (FPC) are often treated with various psychotropic medications. However, evidence regarding their effectiveness in this setting is lacking.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>The study aimed to estimate how different psychotropic medications are associated with the use of coercive measures and recidivism during FPC.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>In this observational national register-based study, we included all patients newly registered as admitted to FPC in Sweden between January 2009 and August 2024. Exposures included major classes of psychotropic medication (typical antipsychotics, atypical antipsychotics, antidepressants, hypnotics and sedatives, antiepileptic medications, opioids, medications for addictive disorders and mood stabilisers), antipsychotic treatment strategies (no use, monotherapy, polypharmacy, long-acting injectables or clozapine) and specific antipsychotic agents. Outcomes were the use of coercive measures and recidivism into criminal behaviour. We performed a within-individual analysis using conditional generalised estimating equation models, where the risk of outcomes was compared between exposed and non-exposed time periods.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Findings<\/jats:title>\n                    <jats:p>In total, 2690 patients were included, of which 25.1% experienced at least one occasion of coercion and 27.1% at least one event of recidivism during FPC. Atypical antipsychotics were associated with a reduced risk of subsequent use of coercive measures (OR 0.70, 95%\u2009CI 0.55 to 0.89)\u2009and recidivism (OR 0.79, 95%\u2009CI 0.63 to 0.99). Medication for addictive disorders was associated with a reduced risk of coercive measures by 34% (OR 0.66, 95%\u2009CI 0.47 to 0.93). Among antipsychotic agents, clozapine was associated with the largest risk reduction in the use of coercive measures (OR 0.48, 95%\u2009CI 0.33 to 0.69) and recidivism (OR 0.49, 95%\u2009CI 0.33 to 0.74). There was no significant difference between long-acting injectable, oral monotherapy or polypharmacy.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>We observed that atypical antipsychotics, especially clozapine, were associated with a risk reduction for coercive measures and recidivism during FPC. Additionally, medications for addictive disorders were associated with a reduced risk of coercive measures.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Clinical implications<\/jats:title>\n                    <jats:p>Our results can help inform decision-making processes in this clinical setting regarding pharmacotherapy but should be interpreted as one of many aspects influencing treatment success in FPC.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/bmjment-2026-302515","type":"journal-article","created":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T11:10:26Z","timestamp":1781694626000},"page":"e302515","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":1,"title":["Association of psychotropic medications with the use of coercive measures and recidivism during forensic psychiatric care: a Swedish nationwide register-based study"],"prefix":"10.1136","volume":"29","author":[{"ORCID":"https:\/\/orcid.org\/0009-0007-3543-131X","authenticated-orcid":false,"given":"Taalke Maria","family":"Sitter","sequence":"first","affiliation":[{"name":"Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suvi","family":"Savinen","sequence":"additional","affiliation":[{"name":"Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden"},{"name":"School of Educational Sciences and Psychology, University of Eastern Finland, Joensuu, Finland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Andin\u00e9","sequence":"additional","affiliation":[{"name":"Center for Ethics, Law and Mental Health, Department of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden"},{"name":"Department of Forensic Psychiatry, Sahlgrenska University Hospital, Gothenburg, Sweden"},{"name":"Department of Forensic Psychiatry, National Board of Forensic Medicine, Stockholm, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anja","family":"Fernqvist","sequence":"additional","affiliation":[{"name":"Center for Ethics, Law and Mental Health, Department of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden"},{"name":"Department of Forensic Psychiatry, National Board of Forensic Medicine, Stockholm, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanna","family":"Edberg","sequence":"additional","affiliation":[{"name":"Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden"},{"name":"Swedish Prison and Probation Service, Norrk\u00f6ping, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3800-6665","authenticated-orcid":false,"given":"Isabell","family":"Brikell","sequence":"additional","affiliation":[{"name":"Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden"},{"name":"Department of Biomedicine, Aarhus University, Aarhus, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian M","family":"D\u2019Onofrio","sequence":"additional","affiliation":[{"name":"Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden"},{"name":"Department of Psychological and Brain Sciences, Indiana University Bloomington, Bloomington, Indiana, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatja","family":"Hirvikoski","sequence":"additional","affiliation":[{"name":"Centre for Psychiatry Research, Region Stockholm, Stockholm, Sweden"},{"name":"Department of Women\u2019s and Children\u2019s Health, Karolinska Institutet, Stockholm, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3765-2067","authenticated-orcid":false,"given":"Ralf","family":"Kuja-Halkola","sequence":"additional","affiliation":[{"name":"Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agnieszka","family":"Szwajda","sequence":"additional","affiliation":[{"name":"Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5383-5365","authenticated-orcid":false,"given":"Seena","family":"Fazel","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, University of Oxford, Oxford, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Nilsson","sequence":"additional","affiliation":[{"name":"Center for Ethics, Law and Mental Health, Department of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden"},{"name":"Department of Forensic Psychiatry, Sahlgrenska University Hospital, Gothenburg, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8087-1417","authenticated-orcid":false,"given":"Zheng","family":"Chang","sequence":"additional","affiliation":[{"name":"Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2026,6,17]]},"reference":[{"key":"2026091806103047000_29.1.e302515.1","doi-asserted-by":"crossref","DOI":"10.1192\/j.eurpsy.2025.10031","article-title":"Pharmacological treatment and psychiatric polypharmacy in forensic psychiatric care in Sweden","volume":"68","author":"Sitter","year":"2025","journal-title":"Eur Psychiatry"},{"key":"2026091806103047000_29.1.e302515.2","doi-asserted-by":"crossref","DOI":"10.3389\/fpsyt.2020.00263","article-title":"The Prevalence and Factors Associated With Antipsychotic Polypharmacy in a Forensic Psychiatric Sample","volume":"11","author":"Farrell","year":"2020","journal-title":"Front Psychiatry"},{"key":"2026091806103047000_29.1.e302515.3","doi-asserted-by":"crossref","DOI":"10.3389\/fpsyt.2019.00963","article-title":"Pharmacological Treatment in Forensic Psychiatry-A Systematic Review","volume":"10","author":"Howner","year":"2019","journal-title":"Front Psychiatry"},{"key":"2026091806103047000_29.1.e302515.4","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1016\/S2215-0366(24)00164-0","article-title":"Forensic mental health: envisioning a more empirical future","volume":"11","author":"Tully","year":"2024","journal-title":"Lancet Psychiatry"},{"key":"2026091806103047000_29.1.e302515.5","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.eurpsy.2017.12.007","article-title":"European Psychiatric Association (EPA) guidance on forensic psychiatry: Evidence based assessment and treatment of mentally disordered offenders","volume":"51","author":"V\u00f6llm","year":"2018","journal-title":"Eur Psychiatry"},{"key":"2026091806103047000_29.1.e302515.6","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2016.15380"},{"key":"2026091806103047000_29.1.e302515.7","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1016\/S0140-6736(13)60733-3","article-title":"Comparative efficacy and tolerability of 15 antipsychotic drugs in schizophrenia: a multiple-treatments meta-analysis","volume":"382","author":"Leucht","year":"2013","journal-title":"The Lancet"},{"key":"2026091806103047000_29.1.e302515.8","doi-asserted-by":"crossref","first-page":"3792","DOI":"10.1017\/S0033291721000556","article-title":"Associations between individual antipsychotics and the risk of arrests and convictions of violent and other crime: a nationwide within-individual study of 74 925 persons","volume":"52","author":"Sariaslan","year":"2022","journal-title":"Psychol Med"},{"key":"2026091806103047000_29.1.e302515.9","doi-asserted-by":"crossref","DOI":"10.3389\/fpsyt.2021.790886","article-title":"Coercive Measures in Psychiatry: A Review of Ethical Arguments","volume":"12","author":"Chieze","year":"2021","journal-title":"Front Psychiatry"},{"key":"2026091806103047000_29.1.e302515.10","doi-asserted-by":"crossref","DOI":"10.3389\/fpsyt.2019.00491","article-title":"Effects of Seclusion and Restraint in Adult Psychiatry: A Systematic Review","volume":"10","author":"Chieze","year":"2019","journal-title":"Front Psychiatry"},{"key":"2026091806103047000_29.1.e302515.11","unstructured":"Nord\u00e9n E . Brott som beg\u00e5s under r\u00e4ttspsykiatrisk v\u00e5rd [crimes committed under forensic psychiatric care]: brottsf\u00f6rebyggande r\u00e5det. 2019."},{"key":"2026091806103047000_29.1.e302515.12","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.i4515","article-title":"Self controlled case series methods: an alternative to standard epidemiological study designs","volume":"354","author":"Petersen","year":"2016","journal-title":"BMJ"},{"key":"2026091806103047000_29.1.e302515.13","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.ijlp.2013.11.013","article-title":"First report from the Swedish National Forensic Psychiatric Register (SNFPR)","volume":"37","author":"Degl\u2019 Innocenti","year":"2014","journal-title":"Int J Law Psychiatry"},{"key":"2026091806103047000_29.1.e302515.14","unstructured":"Nationellt R\u00e4ttspsykiatriskt Kvalitetsregiste . R\u00e4ttpsyK \u00e5rsrapport 2021. Nationellt R\u00e4ttspsykiatriskt Kvalitetsregister; 2022."},{"key":"2026091806103047000_29.1.e302515.15","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1177\/2032284420950485","article-title":"Constructing criminal insanity: The roles of legislators, judges and experts in Norway, Sweden and the Netherlands","volume":"11","author":"Gr\u00f6ning","year":"2020","journal-title":"New Journal of European Criminal Law"},{"key":"2026091806103047000_29.1.e302515.16","unstructured":"Brottsf\u00f6rebyggande r\u00e5det . Personer lagf\u00f6rda f\u00f6r brott. 2024."},{"key":"2026091806103047000_29.1.e302515.17","doi-asserted-by":"crossref","DOI":"10.3389\/fpsyt.2023.1129993","article-title":"Duration of forensic psychiatric care and subsequent criminal recidivism in individuals sentenced in Sweden between 2009 and 2019","volume":"14","author":"Sivak","year":"2023","journal-title":"Front Psychiatry"},{"key":"2026091806103047000_29.1.e302515.18","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/S2215-0366(24)00366-3","article-title":"Comparative effectiveness of antipsychotic treatment strategies for relapse prevention in first-episode schizophrenia in Finland: a population-based cohort study","volume":"12","author":"Taipale","year":"2025","journal-title":"Lancet Psychiatry"},{"key":"2026091806103047000_29.1.e302515.19","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1515\/em-2014-0021","article-title":"Doubly Robust Estimation with the R Package drgee","volume":"4","author":"Zetterqvist","year":"2015","journal-title":"Epidemiol Methods"},{"key":"2026091806103047000_29.1.e302515.20","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1016\/S0140-6736(14)60379-2","article-title":"Antipsychotics, mood stabilisers, and risk of violent crime","volume":"384","author":"Fazel","year":"2014","journal-title":"The Lancet"},{"key":"2026091806103047000_29.1.e302515.21","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/S2215-0366(23)00366-8","article-title":"Efficacy and effectiveness of antipsychotics in schizophrenia: network meta-analyses combining evidence from randomised controlled trials and real-world data","volume":"11","author":"Efthimiou","year":"2024","journal-title":"Lancet Psychiatry"},{"key":"2026091806103047000_29.1.e302515.22","doi-asserted-by":"publisher","DOI":"10.1017\/S146114571100201X"},{"key":"2026091806103047000_29.1.e302515.23","doi-asserted-by":"crossref","unstructured":"Gardner DM , Teehan MD . Antipsychotics and Their Side Effects. Cambridge: Cambridge University Press, 2010.","DOI":"10.1017\/CBO9780511919237"},{"key":"2026091806103047000_29.1.e302515.24","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1176\/appi.ajp.2020.20010052","article-title":"The Importance of Conduct Disorder in the Treatment of Violence in Schizophrenia: Efficacy of Clozapine Compared With Olanzapine and Haloperidol","volume":"178","author":"Krakowski","year":"2021","journal-title":"Am J Psychiatry"},{"key":"2026091806103047000_29.1.e302515.25","article-title":"Antipsychotic combinations for schizophrenia","volume":"6","author":"Ortiz-Orendain","year":"2017","journal-title":"Cochrane Database Syst Rev"},{"key":"2026091806103047000_29.1.e302515.26","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1111\/inm.12964","article-title":"The effect of long-acting injectable antipsychotic medications compared with oral antipsychotic medications among people with schizophrenia: A systematic review and meta-analysis","volume":"31","author":"Okoli","year":"2022","journal-title":"Int J Ment Health Nurs"},{"key":"2026091806103047000_29.1.e302515.27","doi-asserted-by":"crossref","first-page":"4859","DOI":"10.1038\/s41380-025-03080-3","article-title":"Long term safety of ADHD medication in patients with schizophrenia spectrum disorders","volume":"30","author":"Luykx","year":"2025","journal-title":"Mol Psychiatry"},{"key":"2026091806103047000_29.1.e302515.28","first-page":"S48","article-title":"Psychotic disorders comorbid with attention-deficit hyperactivity disorder: an important knowledge gap","volume":"60","author":"Levy","year":"2015","journal-title":"Can J Psychiatry"},{"key":"2026091806103047000_29.1.e302515.29","doi-asserted-by":"crossref","first-page":"3199","DOI":"10.1017\/S0033291716002154","article-title":"Anticholinergic burden in schizophrenia and ability to benefit from psychosocial treatment programmes: a 3-year prospective cohort study","volume":"46","author":"O\u2019Reilly","year":"2016","journal-title":"Psychol Med"},{"key":"2026091806103047000_29.1.e302515.30","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1002\/bsl.2615","article-title":"Risk, resilience, and recovery in forensic mental health: An integrated conceptual model","volume":"41","author":"Penney","year":"2023","journal-title":"Behavioral Sci & The Law"}],"container-title":["BMJ Mental Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjment-2026-302515","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T13:11:03Z","timestamp":1789737063000},"score":1,"resource":{"primary":{"URL":"https:\/\/mentalhealth.bmj.com\/lookup\/doi\/10.1136\/bmjment-2026-302515"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":30,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,6,17]]},"published-print":{"date-parts":[[2026,6]]}},"alternative-id":["10.1136\/bmjment-2026-302515"],"URL":"https:\/\/doi.org\/10.1136\/bmjment-2026-302515","relation":{},"ISSN":["2755-9734"],"issn-type":[{"value":"2755-9734","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6]]}}}